Peter Klotz

614 total citations
27 papers, 414 citations indexed

About

Peter Klotz is a scholar working on Neurology, Cellular and Molecular Neuroscience and Language and Linguistics. According to data from OpenAlex, Peter Klotz has authored 27 papers receiving a total of 414 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Neurology, 6 papers in Cellular and Molecular Neuroscience and 6 papers in Language and Linguistics. Recurrent topics in Peter Klotz's work include Parkinson's Disease Mechanisms and Treatments (10 papers), Neurological disorders and treatments (7 papers) and Genetic Neurodegenerative Diseases (6 papers). Peter Klotz is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (10 papers), Neurological disorders and treatments (7 papers) and Genetic Neurodegenerative Diseases (6 papers). Peter Klotz collaborates with scholars based in Germany, Switzerland and Israel. Peter Klotz's co-authors include H. Przuntek, Carsten Saft, Oliver Goetze, P Kraus, Ubaldo Bonuccelli, David J. Brooks, Paul Morrish, Amos D. Korczyn, W. Kuhn and Jürgen Andrich and has published in prestigious journals such as JAMA, Neurology and Movement Disorders.

In The Last Decade

Peter Klotz

25 papers receiving 401 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Peter Klotz Germany	12	265	160	123	65	51	27	414
Piotr Robowski Poland	12	266 1.0×	115 0.7×	56 0.5×	66 1.0×	69 1.4×	15	395
Pravin Khemani United States	10	205 0.8×	84 0.5×	58 0.5×	63 1.0×	46 0.9×	27	342
Monique Giroux United States	12	310 1.2×	201 1.3×	37 0.3×	28 0.4×	63 1.2×	27	418
M. Loi Italy	9	144 0.5×	96 0.6×	73 0.6×	91 1.4×	39 0.8×	11	382
Susanne Steinlechner Germany	10	350 1.3×	183 1.1×	81 0.7×	42 0.6×	64 1.3×	18	464
Guillaume Dolbeau France	9	122 0.5×	144 0.9×	53 0.4×	35 0.5×	35 0.7×	12	438
Valeria Prada Italy	11	116 0.4×	139 0.9×	60 0.5×	33 0.5×	30 0.6×	38	352
I.M. Donaldson New Zealand	13	174 0.7×	163 1.0×	71 0.6×	71 1.1×	71 1.4×	32	516
Katie Wiltshire Canada	5	242 0.9×	327 2.0×	255 2.1×	49 0.8×	25 0.5×	6	517
G. Defer France	8	261 1.0×	101 0.6×	37 0.3×	26 0.4×	76 1.5×	20	377

Countries citing papers authored by Peter Klotz

Since Specialization

Citations

This map shows the geographic impact of Peter Klotz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Klotz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Klotz more than expected).

Fields of papers citing papers by Peter Klotz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Klotz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Klotz. The network helps show where Peter Klotz may publish in the future.

Co-authorship network of co-authors of Peter Klotz

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Klotz. A scholar is included among the top collaborators of Peter Klotz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Klotz. Peter Klotz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Klotz, Peter. (2019). Werten.

Klotz, Peter. (2017). Modifizieren.

Lee, De-Hyung, Harald Heidecke, Alexandra Schröder, et al.. (2014). Increase of angiotensin II type 1 receptor auto-antibodies in Huntington’s disease. Molecular Neurodegeneration. 9(1). 49–49. 23 indexed citations

Klotz, Peter. (2013). Beschreiben : Grundzüge einer Deskriptologie. E. Schmidt eBooks. 2 indexed citations

Schröder, Alexandra, Peter Klotz, De-Hyung Lee, Ralf Gold, & Ralf A. Linker. (2011). Stability of cognitive functions under mitoxantrone therapy in patients with progressive multiple sclerosis: A pilot analysis. Clinical Neurology and Neurosurgery. 113(7). 527–530. 4 indexed citations

Andrich, Jürgen, et al.. (2009). Upper gastrointestinal findings in Huntington’s disease: patients suffer but do not complain. Journal of Neural Transmission. 116(12). 1607–1611. 42 indexed citations

Klotz, Peter, Dennis Tappe, Marianne Abele‐Horn, et al.. (2006). Cerebral mass in a 13-year-old girl following long-term sojourn in the Tropics. Journal of Medical Microbiology. 55(3). 345–347. 9 indexed citations

Kraus, Peter H., et al.. (2004). Analysis of the course of Parkinson's disease under dopaminergic therapy: Performance of “fast tapping” is not a suitable parameter. Movement Disorders. 20(3). 348–354. 12 indexed citations

Neuner, Burton, et al.. (2002). A self-organizing neural net clustering Parkinson patients and control persons using motor data. 56. 118–124. 1 indexed citations

10.

Schulte, Thorsten, Klaus Berger, Sandra Szymanski, et al.. (2001). Double-blind Crossover Trial of Trimethoprim-Sulfamethoxazole in Spinocerebellar Ataxia Type 3/Machado-Joseph Disease. Archives of Neurology. 58(9). 1451–1451. 32 indexed citations

11.

Kraus, P. H., et al.. (2000). Motor performance: normative data, age dependence and handedness. Journal of Neural Transmission. 107(1). 73–85. 16 indexed citations

12.

Klotz, Peter, et al.. (1999). Theoretical basis and problems of quantification of movement disorders.. PubMed. 80. 443–5. 2 indexed citations

13.

Rabey, Jose M., Ubaldo Bonuccelli, David J. Brooks, et al.. (1997). Evaluation of the Short Parkinsonʼs Evaluation Scale. Clinical Neuropharmacology. 20(4). 322–337. 47 indexed citations

14.

Rabey, J. M., Ubaldo Bonuccelli, David J. Brooks, et al.. (1997). Evaluation of the Short Parkinson's Evaluation Scale: a new friendly scale for the evaluation of Parkinson's disease in clinical drug trials.. PubMed. 20(4). 322–37. 58 indexed citations

15.

Gerlach, M., W. Kuhn, Th. M�ller, Peter Klotz, & H. Przuntek. (1996). Sustained-release of levodopa: single dose study of a new formulation. Journal of Neural Transmission. 103(6). 717–727. 1 indexed citations

16.

Kuhn, W., N. Heye, Th. M�ller, et al.. (1996). The motor performance test series in Parkinson's disease is influenced by depression. Journal of Neural Transmission. 103(3). 349–354. 36 indexed citations

17.

Kuhn, W., et al.. (1993). Disturbance of colour perception in Parkinson's disease. Journal of Neural Transmission - Parkinsons Disease and Dementia Section. 6(1). 11–15. 32 indexed citations

18.

Heinz, Andreas, et al.. (1992). Long-term observation of chronic subsutaneous administration of lisuride in the treatment of motor fluctuations in parkinson's disease. Journal of Neural Transmission - Parkinsons Disease and Dementia Section. 4(4). 291–301. 6 indexed citations

19.

Heinz, Andreas, et al.. (1992). Continuous subcutaneous lisuride infusion in OPCA. Journal of Neural Transmission. 90(2). 145–150. 1 indexed citations

20.

Klotz, Peter, et al.. (1987). Assessment of symptoms of Parkinson's disease by apparative methods.. PubMed. 25. 89–96. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact